Patents by Inventor Martin Himmelbauer

Martin Himmelbauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASK1 INHIBITING AGENTS
    Publication number: 20240109867
    Abstract: Provided are compounds of Formula (I): including compounds of Formulas (II), (III) and (IV), wherein X, R1, R2, R3 and n are as defined herein, and pharmaceutically acceptable salts thereof, and methods for their use and production. These compounds can be useful, e.g., in the treatment of disorders responsive to the inhibition of apoptosis signal-regulating kinase 1 (ASK1).
    Type: Application
    Filed: October 5, 2023
    Publication date: April 4, 2024
    Inventors: Felix Gonzalez Lopez de Turiso, Michael Dechantsreiter, Zhili Xin, John H. Jones, Martin Himmelbauer
  • PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS
    Publication number: 20240083900
    Abstract: Provided are compounds of Formula (I?): or pharmaceutically acceptable salts thereof, wherein the variables in the formula are as defined herein; and methods for their use and production.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 14, 2024
    Applicant: BIOGEN MA INC.
    Inventors: Brian T. Hopkins, Bin Ma, Isaac Marx, Jürgen Schulz, George Vandeveer, Robin Prince, Marta Nevalainen, TeYu Chen, Zain Yousaf, Martin Himmelbauer, Vatee Pattaropong, John Howard Jones, Edward Yin-Shiang Lin, Felix Gonzalez Lopez de Turiso, Thomas Purgett, Andrew George Capacci, Simone Sciabola
  • ASK1 inhibiting agents
    Patent number: 11814362
    Abstract: Provided are compounds of Formula (I): including compounds of Formulas (II), (III) and (IV), wherein X, R1, R2, R3 and n are as defined herein, and pharmaceutically acceptable salts thereof, and methods for their use and production. These compounds can be useful, e.g., in the treatment of disorders responsive to the inhibition of apoptosis signal-regulating kinase 1 (ASK1).
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: November 14, 2023
    Assignee: BIOGEN MA INC.
    Inventors: Felix Gonzalez Lopez de Turiso, Michael Dechantsreiter, Zhili Xin, John H. Jones, Martin Himmelbauer
  • ASK1 inhibiting agents
    Patent number: 11168095
    Abstract: Provided are compounds of Formulas (I?), (I), (II?) and (II), or pharmaceutically acceptable salts thereof, and methods for their use and production.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: November 9, 2021
    Assignee: BIOGEN MA INC.
    Inventors: Felix Gonzalez Lopez de Turiso, Martin Himmelbauer, Michael J. Luzzio
  • ASK1 INHIBITING AGENTS
    Publication number: 20210317103
    Abstract: Provided are compounds of Formula (I): Formula (I), including compounds of Formulas (II), (III), (IV), (V) and (VI), wherein X, R1, R2, R3, R4 and n are as defined herein, and pharmaceutically acceptable salts thereof, and methods for their use and production. These compounds can be useful, e.g., in the treatment of disorders responsive to the inhibition of apoptosis signal-regulating kinase 1 (ASK1).
    Type: Application
    Filed: August 13, 2019
    Publication date: October 14, 2021
    Inventors: Felix Gonzalez Lopez de Turiso, Zhili Xin, Martin Himmelbauer, John H. Jones
  • ASK1 INHIBITING AGENTS
    Publication number: 20210115020
    Abstract: Provided are compounds of Formula (I): including compounds of Formulas (II), (III) and (IV), wherein X, R1, R2, R3 and n are as defined herein, and pharmaceutically acceptable salts thereof, and methods for their use and production. These compounds can be useful, e.g., in the treatment of disorders responsive to the inhibition of apoptosis signal-regulating kinase 1 (ASK1).
    Type: Application
    Filed: June 26, 2019
    Publication date: April 22, 2021
    Inventors: Felix Gonzalez Lopez de Turiso, Michael Dechantsreiter, Zhili Xin, John H. Jones, Martin Himmelbauer
  • ASK1 INHIBITING AGENTS
    Publication number: 20190359634
    Abstract: Provided are compounds of Formulas (I?), (I), (II?) and (II), or pharmaceutically acceptable salts thereof, and methods for their use and production.
    Type: Application
    Filed: February 6, 2018
    Publication date: November 28, 2019
    Applicant: BIOGEN MA INC.
    Inventors: Felix Gonzalez Lopez de Turiso, Martin Himmelbauer, Michael J. Luzzio